Drug Trial Radar · NCT04343287
Safety and Efficacy of BRM421 for Dry Eye Syndrome Treatment
Last checked: Nov 19, 2026Latest source record: May 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
220
Actual
Start
Jan 15, 2020
Primary completion
Jun 23, 2020
Study completion Jun 23, 2020
Sponsor
- Lead sponsor
- BRIM Biotechnology Inc.Industry
- Sponsor type
- Industry
- First posted
- Apr 13, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study is to compare the safety and efficacy of BRM421 Ophthalmic Solution to placebo for the treatment of the signs and symptoms of dry eye.
Conditions
- Dry Eye Syndrome
Interventions
BRM421Drug
The active control with BRM421 solution
PlaceboDrug
The vehicle solution
Primary outcomes
What the sponsor says the trial is designed to measure.
- Ocular Sign: Change From Baseline in Total Corneal Staining Score to Day 14Time frame: change from baseline to 2 weeks
- Ocular Symptom: Change From Baseline in Patient-Reported Ocular Dryness Score to Day 14, Using Ora Calibra® Ocular Discomfort & 4-Symptom QuestionnaireTime frame: change from baseline to 2 weeks
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Eye Research Foundation
Newport Beach, California
Midwest Cornea Associates, LLC
Indianapolis, Indiana
Andover Eye Associates
Andover, Massachusetts
Total Eye Care
Memphis, Tennessee
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.